Accepted Manuscripts                   Back to the articles list | Back to browse issues page

XML Print

Abstract:   (284 Views)
Multiple sclerosis (MS) is a central nervous system (CNS) chronic disease in which axons are demyelinated and signal conduction is slowed or blocked. Unfortunately, current drugs that are used to treat MS have limited efficiency and considerable side effects. The use of bioactive natural products for treating neurodegenerative diseases has become of great interest due to their multimodal mechanism of action and potential safety. However, pharmacokinetic parameters such as bioavailability, absorption, metabolic pathways and elimination routes are essential for evaluating the efficacy and toxicity of herbal medicines and herbal preparations in clinic. In this review, we have summarized different pharmacokinetic parameters of neuroprotective natural products with anti-experimental autoimmune encephalomyelitis (EAE) effects and recent developments in strategies to improve their bioavailability and effectiveness.
Types of Manuscript: Review | Subject: Pharmacokinetics/Dynamics

1. Ahmad I, Anwar M, Akhter S, Thakur P, Chawla R, Sharma RK, et al. Supercritical fluid technology-based trans-resveratrol SLN for long circulation and improved radioprotection. J Pharm Innov 2016; 11(4): 308-22. [DOI:10.1007/s12247-016-9254-9]
2. Aires V, Limagne E, Cotte AK, Latruffe N, Ghiringhelli F, Delmas D. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death. Mol Nutr Food Res 2013; 57(7): 1170-81. [DOI:10.1002/mnfr.201200766]
3. Alkharfy KM, Ahmad A, Khan RMA, Al-Shagha WM. Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. Eur J Drug Metab Pharmacokinet 2015; 40(3): 319-23. [DOI:10.1007/s13318-014-0207-8]
4. Arozal W, Louisa M, Rahmat D, Chendrana P, Sandhiutami NMD. Development, characterization and pharmacokinetic profile of chitosan-sodium tripolyphosphate nanoparticles based drug delivery systems for curcumin. Adv Pharm Bull 2021; 11(1): 77-85. [DOI:10.34172/apb.2021.008]
5. Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple sclerosis: Mechanisms and immunotherapy. Neuron 2018; 97(4): 742-68. [DOI:10.1016/j.neuron.2018.01.021]
6. Barros Silva R, Santos NAG, Martins NM, Ferreira DAS, Barbosa Jr. F, Oliveira Souza V, et al. Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats. Neuroscience 2013; 233: 86-94. [DOI:10.1016/j.neuroscience.2012.12.041]
7. Becher B, Durell BG, Noelle RJ. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 2002; 110(4): 493-7. [DOI:10.1172/JCI0215751]
8. Bera R, Ahmed SKM, Sarkar L, Sen T, Karmakar S. Pharmacokinetic analysis and tissue distribution of andrographolide in rat by a validated LC-MS/MS method. Pharm Biol 2014; 52(3): 321-9. [DOI:10.3109/13880209.2013.836544]
9. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine 2002; 9(Suppl 3): 1-33. [DOI:10.1078/1433-187X-00210]
10. Bornheim LM, Kim KY, Li J, Perotti BY, Benet LZ. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab Dispos 1995; 23(8): 825-31.
11. Calabrese EJ, Mattson MP, Calabrese V. Resveratrol commonly displays hormesis: Occurrence and biomedical significance. Hum Exp Toxicol 2010; 29(12): 980-1015. [DOI:10.1177/0960327110383625]
12. Cayen MN, Ferdinandi ES, Greselin E, Dvornik D. Studies on the disposition of diosgenin in rats, dogs, monkeys and man. Atherosclerosis 1979; 33(1): 71-87. [DOI:10.1016/0021-9150(79)90199-0]
13. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, et al. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2014; 12(12): 2092-103.e1-6. [DOI:10.1016/j.cgh.2014.02.024]
14. Chandrasekaran B, Nagarajan B. Metabolism of echitamine and plumbagin in rats. J Biosci 1981; 3(4): 395-400. [DOI:10.1007/BF02702627]
15. Chang HC, Churchwell MI, Delclos KB, Newbold RR, Doerge DR. Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr 2000; 130(8): 1963-70. [DOI:10.1093/jn/130.8.1963]
16. Chen X, Pi R, Zou Y, Liu M, Ma X, Jiang Y, et al. Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin. Eur J Pharmacol 2010; 629(1-3): 40-6. [DOI:10.1016/j.ejphar.2009.12.008]
17. Cheng S, Qiu F, Wang S, He J. HPLC analysis and pharmacokinetics of icariin in rats. J Sep Sci 2007; 30(9): 1307-12. [DOI:10.1002/jssc.200600313]
18. Cheng T, Zhang Y, Zhang T, Lu L, Ding Y, Zhao Y. Comparative pharmacokinetics study of icariin and icariside II in rats. Molecules 2015; 20(12): 21274-86. [DOI:10.3390/molecules201219763]
19. Chitnis T, Khoury SJ. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol Res 2003; 28: 223-39. [DOI:10.1385/IR:28:3:223]
20. Chu Y, Jing Y, Zhao X, Wang M, Zhang M, Ma R, et al. Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis. J Neuroimmunol 2021; 352: 577480. [DOI:10.1016/j.jneuroim.2021.577480]
21. Chu YJ, Ma WD, Thome R, Ping JD, Liu FZ, Wang MR, et al. Matrine inhibits CNS autoimmunity through an IFN-β-dependent mechanism. Front Immunol 2020; 11: 569530. [DOI:10.3389/fimmu.2020.569530]
22. Chung JH, Manganiello V, Dyck JR. Resveratrol as a calorie restriction mimetic: Therapeutic implications. Trends Cell Biol 2012; 22(10): 546-54. [DOI:10.1016/j.tcb.2012.07.004]
23. Ciftci O, Ozcan C, Kamisli O, Cetin A, Basak N, Aytac B. Hesperidin, a Citrus flavonoid, has the ameliorative effects against experimental autoimmune encephalomyelitis (EAE) in a C57BL/J6 mouse model. Neurochem Res 2015; 40(6): 1111-20. [DOI:10.1007/s11064-015-1571-8]
24. Dong X, Zhang D, Zhang L, Li W, Meng X. Osthole improves synaptic plasticity in the hippocampus and cognitive function of Alzheimer's disease rats via regulating glutamate. Neural Regen Res 2012; 7(30): 2325-32.
25. Dong Z, Ma D, Gong Y, Yu T, Yao G. Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses. Neurosci Lett 2016; 619: 92-9. [DOI:10.1016/j.neulet.2016.01.008]
26. Dowd FJ. Pharmacokinetics: The absorption, distribution, and fate of drugs In: Dowd FJ, Johnson BS and Mariotti AJ, editors. Pharmacology and Therapeutics for Dentistry (Seventh Edition): Mosby, 2017: 15-43. [DOI:10.1016/B978-0-323-39307-2.00002-3]
27. Du Y, Zhang Q, Chen GG, Wei P, Tu CY. Pharmacokinetics of astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometry. Eur J Drug Metab Pharmacokinet 2005; 30(4): 269-73. [DOI:10.1007/BF03190631]
28. Emami SA, Sahebkar A, Javadi B. Paresthesia: A review of its definition, etiology and treatments in view of the traditional medicine. Curr Pharm Des 2016; 22(3): 321-7. [DOI:10.2174/1381612822666151112145348]
29. Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B. Silymarin impacts on immune system as an immunomodulator: One key for many locks. Int Immunopharmacol 2017; 50: 194-201. [DOI:10.1016/j.intimp.2017.06.030]
30. Feng Q, Xu S, Yu J, Sun S, Yang L. Determination of epimedin B in rat plasma and tissue by LC-MS/MS: Application in pharmacokinetic and tissue distribution studies. J Anal Methods Chem 2017; 2017: 7194075. [DOI:10.1155/2017/7194075]
31. Gao Q. Elucidation of arctigenin biotransformation through its biopharmaceutics and pharmacokinetics profiling. The Chinese University of Hong Kong (Hong Kong); 2014.
32. Gao Z, Wen Q, Xia Y, Yang J, Gao P, Zhang N, et al. Osthole augments therapeutic efficiency of neural stem cells-based therapy in experimental autoimmune encephalomyelitis. J Pharmacol Sci 2014; 124(1): 54-65. [DOI:10.1254/jphs.13144FP]
33. Gerbeth K, Husch J, Fricker G, Werz O, Schubert-Zsilavecz M, Abdel-Tawab M. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoter apia 2013; 84: 99-106. [DOI:10.1016/j.fitote.2012.10.009]
34. Gescher A, Steward WP, Brown K. Resveratrol in the management of human cancer: How strong is the clinical evidence? Ann N Y Acad Sci 2013; 1290(1): 12-20. [DOI:10.1111/nyas.12205]
35. Ghaiad HR, Nooh MM, El-Sawalhi MM, Shaheen AA. Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: Biochemical and histological study. Mol Neurobiol 2017; 54: 3219-29. [DOI:10.1007/s12035-016-9891-5]
36. Gharagozloo M, Velardi E, Bruscoli S, Agostini M, Di Sante M, Donato V, et al. Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF-κB activity and IL-2 production. Pharmacol Res 2010; 61(5): 405-9. [DOI:10.1016/j.phrs.2009.12.017]
37. Giacoppo S, Galuppo M, Pollastro F, Grassi G, Bramanti P, Mazzon E. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis. Daru 2015; 23: 48. [DOI:10.1186/s40199-015-0131-8]
38. Gill EW, Jones G. Brain levels of Δ1-tetrahydrocannabinol and its metabolites in mice-correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide. Biochem Pharmacol 1972; 21(16): 2237-48. [DOI:10.1016/0006-2952(72)90039-1]
39. Gordi T, Huong DX, Hai TN, Nieu NT, Ashton M. Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimens. Antimicrob Agents Chemother 2002; 46(4): 1026-31. [DOI:10.1128/AAC.46.4.1026-1031.2002]
40. Gu B, Zeng Y, Yin C, Wang H, Yang X, Wang S, et al. Sinomenine reduces iNOS expression via inhibiting the T-bet IFN-γ pathway in experimental autoimmune encephalomyelitis in rats. J Biomed Res 2012; 26(6): 448-55. [DOI:10.7555/JBR.26.20110114]
41. Gu Y, Wang G, Fawcett JP. Determination of astragaloside IV in rat plasma by liquid chromatography electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 801(2): 285-8. [DOI:10.1016/j.jchromb.2003.11.033]
42. Haghmorad D, Mahmoudi MB, Salehipour Z, Jalayer Z, Momtazi Brojeni AA, Rastin M, et al. Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis. J Neuroimmunol 2017; 302: 23-33. [DOI:10.1016/j.jneuroim.2016.11.009]
43. Han LY, Wu YL, Zhu CY, Wu CS, Yang CR. Improved pharmacokinetics of icariin (ICA) within formulation of PEG-PLLA/PDLA-PNIPAM polymeric micelles. Pharmaceutics 2019; 11(2): 51. [DOI:10.3390/pharmaceutics11020051]
44. He Y, Du M, Gao Y, Liu H, Wang H, Wu X, et al. Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels. PLoS One 2013; 8(10): e76495. [DOI:10.1371/journal.pone.0076495]
45. He YX, Du M, Shi HL, Huang F, Liu HS, Wu H, et al. Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL/6 mice at multiple levels. BMC Complement Altern Med 2014; 14: 313. [DOI:10.1186/1472-6882-14-313]
46. Hikim APS, Lue YH, Wang C, Reutrakul V, Sangsuwan R, Swerdloff RS. Posttesticular antifertility action of triptolide in the male rat: Evidence for severe impairment of cauda epididymal sperm ultrastructure. J Androl 2000; 21(3): 431-7.
47. Hsieh YJ, Lin LC, Tsai TH. Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 844(1): 1-5. [DOI:10.1016/j.jchromb.2006.06.024]
48. Huang H, Zhang Y, Yang R, Tang X. Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 874(1): 77-83. [DOI:10.1016/j.jchromb.2008.09.005]
49. Huynh PN, Hikim APS, Wang C, Stefonovic K, Lue YH, Leung A, et al. Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats. J Androl 2000; 21(5): 689-99.
50. Ilhan A, Akyol O, Gurel A, Armutcu F, Iraz M, Oztas E. Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats. Free Radic Biol Med 2004; 37(3): 386-94. [DOI:10.1016/j.freeradbiomed.2004.04.022]
51. Imler TJ, Petro TM. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4- IFN-γ+ cells, and decreased macrophage IL-6 expression. Int Immunopharmacol 2009; 9(1): 134-43. [DOI:10.1016/j.intimp.2008.10.015]
52. Iruretagoyena MI, Sepúlveda SE, Lezana JP, Hermoso M, Bronfman M, Gutiérrez MA, et al. Inhibition of nuclear factor-κB enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 2006; 318(1): 59-67. [DOI:10.1124/jpet.106.103259]
53. Iruretagoyena MI, Tobar JA, González PA, Sepúlveda SE, Figueroa CA, Burgos RA, et al. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther 2005; 312(1): 366-72. [DOI:10.1124/jpet.104.072512]
54. Jeffrey P, Summerfield S. Assessment of the blood-brain barrier in CNS drug discovery. Neurobiol Dis 2010; 37(1): 33-7. [DOI:10.1016/j.nbd.2009.07.033]
55. Jia Y, Jing J, Bai Y, Li Z, Liu L, Luo J, et al. Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways. PLoS One 2011; 6(10): e27006. [DOI:10.1371/journal.pone.0027006]
56. Jia Y, Li Z, Cai W, Xiao D, Han S, Han F, et al. SIRT1 regulates inflammation response of macrophages in sepsis mediated by long noncoding RNA. Biochim Biophys Acta Mol Basis Dis 2018; 1864(3): 784-92. [DOI:10.1016/j.bbadis.2017.12.029]
57. Jiang Y, Wu A, Zhu C, Pi R, Chen S, Liu Y, et al. The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis. Neurol Res 2013; 35(4): 360-8. [DOI:10.1179/1743132812Y.0000000156]
58. Jose S, Anju SS, Cinu TA, Aleykutty NA, Thomas S, Souto EB. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int J Pharm 2014; 474(1-2): 6-13. [DOI:10.1016/j.ijpharm.2014.08.003]
59. Kanakasabai S, Casalini E, Walline CC, Mo C, Chearwae W, Bright JJ. Differential regulation of CD4+ T helper cell responses by curcumin in experimental autoimmune encephalomyelitis. J Nutr Biochem 2012; 23(11): 1498-507. [DOI:10.1016/j.jnutbio.2011.10.002]
60. Kanaze F, Bounartzi M, Georgarakis M, Niopas I. Pharmacokinetics of the Citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007; 61(4): 472-7. [DOI:10.1038/sj.ejcn.1602543]
61. Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 2011; 68(3): 593-601. [DOI:10.1007/s00280-010-1525-4]
62. Kiasalari Z, Afshin-Majd S, Baluchnejadmojarad T, Azadi-Ahmadabadi E, Fakour M, Ghasemi-Tarie R, et al. Sinomenine alleviates murine experimental autoimmune encephalomyelitis model of multiple sclerosis through inhibiting NLRP3 inflammasome. J Mol Neurosci 2021; 71(2): 215-24. [DOI:10.1007/s12031-020-01637-1]
63. Kohlert C, Van Rensen I, März R, Schindler G, Graefe E, Veit M. Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans. Planta Med 2000; 66(6): 495-505. [DOI:10.1055/s-2000-8616]
64. Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, et al. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol 2011; 163(7): 1507-19. [DOI:10.1111/j.1476-5381.2011.01379.x]
65. Lai MY, Hsiu SL, Tsai SY, Hou YC, Chao PD. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. J Pharm Pharmacol 2003; 55(2): 205-9. [DOI:10.1211/002235702522]
66. Lassmann H. Multiple sclerosis pathology. Cold Spring Harb Perspect Med 2018; 8(3): a028936. [DOI:10.1101/cshperspect.a028936]
67. Lee CJ, Wu YT, Hsueh TY, Lin LC, Tsai TH. Pharmacokinetics and oral bioavailability of epimedin C after oral administration of epimedin C and Herba Epimedii extract in rats. Biomed Chromatogr 2014; 28(5): 630-6. [DOI:10.1002/bmc.3081]
68. Leuschner JT, Harvey DJ, Bullingham RE, Paton WD. Pharmacokinetics of delta 9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses. Drug Metab Dispos 1986; 14(2): 230-8.
69. Li N, Ye Y, Yang M, Jiang X, Ma J. Pharmacokinetics of baicalin-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration. Pharmazie 2011; 66(5): 374-7.
70. Li W, Zhang Z, Zhang K, Xue Z, Li Y, Zhang Z, et al. Arctigenin suppress Th17 cells and ameliorates experimental autoimmune encephalomyelitis through AMPK and PPAR-γ/ROR-γt signaling. Mol Neurobiol 2016; 53(8): 5356-66. [DOI:10.1007/s12035-015-9462-1]
71. Li X, Li TT, Zhang XH, Hou LF, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell. PLoS One 2013; 8(8): e74108. [DOI:10.1371/journal.pone.0074108]
72. Li Y, Duan J, Guo T, Xie W, Yan S, Li B, et al. In vivo pharmacokinetics comparisons of icariin, emodin and psoralen from Gan-kang granules and extracts of Herba Epimedii, Nepal dock root, Ficus hirta yahl. J Ethnopharmacol 2009; 124(3): 522-9. [DOI:10.1016/j.jep.2009.05.008]
73. Li YX, Zhang RQ, Li CR, Jiang XH. Pharmacokinetics of huperzine A following oral administration to human volunteers. Eur J Drug Metab Pharmacokinet 2007; 32(4): 183-7. [DOI:10.1007/BF03191002]
74. Li Z, Ji H, Song X, Hu J, Han N, Chen N. Osthole attenuates the development of carrageenan-induced lung inflammation in rats. Int Immunopharmacol 2014; 20(1): 33-6. [DOI:10.1016/j.intimp.2014.02.013]
75. Liang M, Chen Y, Zhang L, Li L, Chen G, Yin L. Epimedium flavonoids ameliorate neuropathological changes and increases IGF-1 expression in C57BL/6 mice exposed to cuprizone. Neurochem Res 2015; 40(3): 492-500. [DOI:10.1007/s11064-014-1490-0]
76. Liu ZQ, Chan K, Zhou H, Jiang ZH, Wong YF, Xu HX, et al. The pharmacokinetics and tissue distribution of sinomenine in rats and its protein binding ability in vitro. Life Sci 2005; 77(25): 3197-209. [DOI:10.1016/j.lfs.2005.05.054]
77. Ma W, Zhang M, Liu S, Wang M, Shi Y, Yang T, et al. Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis. Neurosci Lett 2020; 715: 134599. [DOI:10.1016/j.neulet.2019.134599]
78. Ma X, Jiang Y, Wu A, Chen X, Pi R, Liu M, et al. Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. PLoS One 2010; 5(10): e13489. [DOI:10.1371/journal.pone.0013489]
79. Mandala Rayabandla S K, Aithal K, Anandam A, Shavi G, Nayanabhirama U, Arumugam K, et al. Preparation, in vitro characterization, pharmacokinetic, and pharmacodynamic evaluation of chitosan-based plumbagin microspheres in mice bearing B16F1 melanoma. Drug Deliv 2010; 17(3): 103-13. [DOI:10.3109/10717540903548447]
80. McPartland JM, Russo EB. Cannabis and Cannabis extracts. J Cannabis Ther 2001; 1(3-4): 103-32. [DOI:10.1300/J175v01n03_08]
81. Mohamed A, Shoker A, Bendjelloul F, Mare A, Alzrigh M, Benghuzzi H, et al. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomed Sci Instrum 2003; 39: 440-5.
82. Mohtashami L, Shakeri A, Javadi B. Neuroprotective natural products against experimental autoimmune encephalomyelitis: A review. Neurochem Int 2019; 129: 104516. [DOI:10.1016/j.neuint.2019.104516]
83. More SK, Pawar AP. Preparation, optimization and preliminary pharmacokinetic study of curcumin encapsulated turmeric oil microemulsion in zebra fish. Eur J Pharm Sci 2020; 155: 105539. [DOI:10.1016/j.ejps.2020.105539]
84. Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, et al. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Δ9-tetrahydrocannabinol (THC) after oral application of THC verses standardized Cannabis extract. Ther Drug Monit 2005; 27(6): 799-810. [DOI:10.1097/01.ftd.0000177223.19294.5c]
85. Nahas G, Leger C, Tocque B, Hoellinger H. The kinetics of cannabinoid distribution and storage with special reference to the brain and testis. J Clin Pharmacol 1981; 21(S1): 208S-14S. [DOI:10.1002/j.1552-4604.1981.tb02597.x]
86. Nahas GG. The pharmacokinetics of THC in fat and brain: Resulting functional responses to marihuana smoking. Hum Psychopharmacol 2001; 16(3): 247-55. [DOI:10.1002/hup.258]
87. Nencini C, Giorgi G, Micheli L. Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine 2007; 14(2-3): 129-35. [DOI:10.1016/j.phymed.2006.02.005]
88. Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 1980; 28(3): 409-16. [DOI:10.1038/clpt.1980.181]
89. Pandita D, Kumar S, Poonia N, Lather V. Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res Int 2014; 62: 1165-74. [DOI:10.1016/j.foodres.2014.05.059]
90. Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, et al. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 2000; 7(5): 351-64. [DOI:10.1016/S0944-7113(00)80054-9]
91. Patel KR, Andreadi C, Britton RG, Horner-Glister E, Karmokar A, Sale S, et al. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci Transl Med 2013; 5(205): 205ra133. [DOI:10.1126/scitranslmed.3005870]
92. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 1990; 2(6): 539-44. [DOI:10.1093/intimm/2.6.539]
93. Qin X, Guo BT, Wan B, Fang L, Lu L, Wu L, et al. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine. J Immunol 2010; 185(3): 1855-63. [DOI:10.4049/jimmunol.0903853]
94. Razeghi Jahromi S, Arrefhosseini SR, Ghaemi A, Alizadeh A, Sabetghadam F, Togha M. Effect of oral genistein administration in early and late phases of allergic encephalomyelitis. Iran J Basic Med Sci 2014; 17(7): 509-15.
95. Razeghi S, Aref Hosseini SR, Ebrahimi Mamaghani M, Togha M, Roushangar L, Tarihi T. Prevention of animal model of multiple sclerosis by oral genistein, extracted from soy bean. Iran J Neurol 2009; 7: 507-17.
96. Roberts SA. Drug Metabolism | Overview. In: Worsfold P, Townshend A and Poole C, editors. Encyclopedia of Analytical Science (Second Edition): Elsevier, 2005: 293-305. [DOI:10.1016/B0-12-369397-7/00108-4]
97. Roohbakhsh A, Parhiz H, Soltani F, Rezaee R, Iranshahi M. Neuropharmacological properties and pharmacokinetics of the Citrus flavonoids hesperidin and hesperetin-A mini-review. Life Sci 2014; 113(1): 1-6. [DOI:10.1016/j.lfs.2014.07.029]
98. Ross TM, Martinez PM, Renner JC, Thorne RG, Hanson LR, Frey II WH. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: A non-invasive treatment strategy for multiple sclerosis. J Neuroimmunol 2004; 151(1-2): 66-77. [DOI:10.1016/j.jneuroim.2004.02.011]
99. Samoilova EB, Horton JL, Hilliard B, Liu TST, Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 1998; 161(12): 6480-6.
100. Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I. Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol 2013; 183(5): 1390-6. [DOI:10.1016/j.ajpath.2013.07.006]
101. Setchell KDR, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001; 131(4): 1362S-75S. [DOI:10.1093/jn/131.4.1362S]
102. Shao F, Wang G, Xie H, Zhu X, Sun J, A J. Pharmacokinetic study of triptolide, a constituent of immunosuppressive Chinese herb medicine, in rats. Biol Pharm Bull 2007; 30(4): 702-7. [DOI:10.1248/bpb.30.702]
103. Shen R, Deng W, Li C, Zeng G. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol 2015; 24(2): 224-31. [DOI:10.1016/j.intimp.2014.12.015]
104. Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol 2010; 30(4): 328-39. [DOI:10.1097/WNO.0b013e3181f7f833]
105. Showalter VM, Compton DR, Martin BR, Abood ME. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996; 278(3): 989-99.
106. Shusen L, Min Z, Jing S, Weilin S. The physiological dispositions of triptolide it rats. Chin Pharmacol Bull 1991.
107. Singh G, Pai RS, Pandit V. In vivo pharmacokinetic applicability of a simple and validated HPLC method for orally administered trans-resveratrol loaded polymeric nanoparticles to rats. J Pharm Investig 2014; 44(2): 69-78. [DOI:10.1007/s40005-013-0105-0]
108. Song M, Hang TJ, Wang Y, Jiang L, Wu XL, Zhang Z, et al. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J Pharm Biomed Anal 2006; 40(1): 190-6. [DOI:10.1016/j.jpba.2005.06.034]
109. Sterk V, Büchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med 2004; 70(12): 1155-60. [DOI:10.1055/s-2004-835844]
110. Stürner KH, Verse N, Yousef S, Martin R, Sospedra M. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling. Eur J Immunol 2014; 44(4): 1200-12. [DOI:10.1002/eji.201343629]
111. Sun YZ, Chen JF, Shen LM, Zhou J, Wang CF. Anti-atherosclerotic effect of hesperidin in LDLr-/- mice and its possible mechanism. Eur J Pharmacol 2017; 815: 109-17. [DOI:10.1016/j.ejphar.2017.09.010]
112. Tao T, Zhao Y, Yue P, Dong WX, Chen QH. Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration. Yao Xue Xue Bao 2006; 41(11): 1104-10.
113. Titulaer HAC, Zuidema J, Kager PA, Wetsteyn JCFM, Lugt CB, Merkus FWHM. The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol 1990; 42(11): 810-3. [DOI:10.1111/j.2042-7158.1990.tb07030.x]
114. Toklu HZ, Akbay TT, Velioglu-Ogunc A, Ercan F, Gedik N, Keyer-Uysal M, et al. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. J Surg Res 2008; 145(2): 214-22. [DOI:10.1016/j.jss.2007.03.072]
115. Tsai T, Chen Y. Determination of unbound hesperetin in rat blood and brain by microdialysis coupled to microbore liquid chromatography. J Food Drug Anal 2000; 8(4): 331-6. [DOI:10.38212/2224-6614.2814]
116. Tsai TH. Concurrent measurement of unbound genistein in the blood, brain and bile of anesthetized rats using microdialysis and its pharmacokinetic application. J Chromatogr A 2005; 1073(1-2): 317-22. [DOI:10.1016/j.chroma.2004.10.048]
117. Tsai YM, Chien CF, Lin LC, Tsai TH. Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 2011; 416(1): 331-8. [DOI:10.1016/j.ijpharm.2011.06.030]
118. Ungerleider JT, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse 1987; 7(1): 39-50. [DOI:10.1300/J251v07n01_04]
119. Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun 2017; 60: 1-12. [DOI:10.1016/j.bbi.2016.03.010]
120. Vijayakumar MR, Vajanthri KY, Balavigneswaran CK, Mahto SK, Mishra N, Muthu MS, et al. Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes. Colloids Surf B Biointerfaces 2016; 145: 479-91. [DOI:10.1016/j.colsurfb.2016.05.037]
121. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004; 32(12): 1377-82. [DOI:10.1124/dmd.104.000885]
122. Wang D, Li SP, Fu JS, Bai L, Guo L. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Int J Dev Neurosci 2016; 49: 60-6. [DOI:10.1016/j.ijdevneu.2016.01.005]
123. Wang J, Chen F, Zheng P, Deng W, Yuan J, Peng B, et al. Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice. Exp Neurol 2012; 236(1): 79-87. [DOI:10.1016/j.expneurol.2012.03.024]
124. Wang J, Qi Y, Niu X, Tang H, Meydani SN, Wu D. Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice. J Nutr Biochem 2018; 54: 130-9. [DOI:10.1016/j.jnutbio.2017.12.004]
125. Wang K, Li Z, Chen Y, Su C. The pharmacokinetics of a novel anti-tumor agent, β-elemene, in Sprague-Dawley rats. Biopharm Drug Dispos 2005a; 26(7): 301-7. [DOI:10.1002/bdd.463]
126. Wang K, Su CY. Pharmacokinetics and disposition of beta-elemene in rats. Yao Xue Xue Bao 2000; 35(10): 725-8.
127. Wang MR, Zhang XJ, Liu HC, Ma WD, Zhang ML, Zhang Y, et al. Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy. Brain Res Bull 2019; 153: 30-8. [DOI:10.1016/j.brainresbull.2019.08.006]
128. Wang X, Pang J, Maffucci JA, Pade DS, Newman RA, Kerwin SM, et al. Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats. Biopharm Drug Dispos 2009; 30(5): 221-8. [DOI:10.1002/bdd.657]
129. Wang X, Wang R, Xing D, Su H, Ma C, Ding Y, et al. Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci 2005b; 77(24): 3058-67. [DOI:10.1016/j.lfs.2005.02.033]
130. Wang Y, Ma Y, Li X, Qin F, Lu X, Li F. Simultaneous determination and pharmacokinetic study of oxymatrine and matrine in beagle dog plasma after oral administration of Kushen formula granule, oxymatrine and matrine by LC-MS/MS. Biomed Chromatogr 2007a; 21(8): 876-82. [DOI:10.1002/bmc.834]
131. Wang Y, Mei Y, Feng D, Xu L. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurosci Res 2008; 86(11): 2441-9. [DOI:10.1002/jnr.21683]
132. Wang Z, Qiu J, Guo TB, Liu A, Wang Y, Li Y, et al. Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis. J Immunol 2007b; 179(9): 5958-65. [DOI:10.4049/jimmunol.179.9.5958]
133. Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab Dispos 2008; 36(1): 65-72. [DOI:10.1124/dmd.107.017566]
134. Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 2005; 49(5): 472-81. [DOI:10.1002/mnfr.200500010]
135. Wight RD, Tull CA, Deel MW, Stroope BL, Eubanks AG, Chavis JA, et al. Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases. Biochem Biophys Res Commun 2012; 426(1): 112-5. [DOI:10.1016/j.bbrc.2012.08.045]
136. Wildfeuer A, Neu IS, Safayhi H, Metzger G, Wehrmann M, Vogel U, et al. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforschung 1998; 48(6): 668-74.
137. Wu XS, Xie T, Lin J, Fan HZ, Huang-Fu HJ, Ni LF, et al. An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J Pharm Pharmacol 2009; 61(12): 1653-6. [DOI:10.1211/jpp.61.12.0010]
138. Wu YT, Chen YF, Hsieh YJ, Jaw I, Shiao MS, Tsai TH. Bioavailability of salvianolic acid B in conscious and freely moving rats. Int J Pharm 2006; 326(1-2): 25-31. [DOI:10.1016/j.ijpharm.2006.07.003]
139. Xiang Y, Long Y, Yang Q, Zheng C, Cui M, Ci Z, et al. Pharmacokinetics, pharmacodynamics and toxicity of baicalin liposome on cerebral ischemia reperfusion injury rats via intranasal administration. Brain Res 2020; 1726: 146503. [DOI:10.1016/j.brainres.2019.146503]
140. Xiao L, Guo D, Hu C, Shen W, Shan L, Li C, et al. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination. Glia 2012; 60(7): 1037-52. [DOI:10.1002/glia.22333]
141. Xie L, Li XK, Funeshima-Fuji N, Kimura H, Matsumoto Y, Isaka Y, et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 2009; 9(5): 575-81. [DOI:10.1016/j.intimp.2009.01.025]
142. Xie MZ, Zhou WZ, Zhang Y. Oxymatrine metabolic fate. Chin Med J 1983; 96(2): 145-50.
143. Xu J, Huang R, Yang YJ, Jin SJ, Zhang JF. Effects of baicalin on apoptosis in rats with autoimmune encephalomyelitis. Zhongguo Dang Dai Er Ke Za Zhi 2011; 13(8): 665-8.
144. Xu L, Liu Y, Wang T, Qi Y, Han X, Xu Y, et al. Development and validation of a sensitive and rapid non-aqueous LC-ESI-MS/MS method for measurement of diosgenin in the plasma of normal and hyperlipidemic rats: A comparative study. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877(14-15): 1530-6. [DOI:10.1016/j.jchromb.2009.03.039]
145. Xu M, Fu G, Qiao X, Wu WY, Guo H, Liu AH, et al. HPLC method for comparative study on tissue distribution in rat after oral administration of salvianolic acid B and phenolic acids from Salvia miltiorrhiza. Biomed Chromatogr 2007; 21: 1052-63. [DOI:10.1002/bmc.852]
146. Xu S, Yu J, Zhan J, Yang L, Guo L, Xu Y. Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat. Biomed Res Int 2017; 2017: 4684962. [DOI:10.1155/2017/4684962]
147. Xu X, Lv Y, Tang K, Song B, Jiang Q, Sun L, et al. The simultaneous determination of naringenin and its valine carbamate prodrug in rat plasma using supercritical fluid chromatography-tandem mass spectrometric method. J Pharm Biomed Anal 2021; 195: 113848. [DOI:10.1016/j.jpba.2020.113848]
148. Yang L, Han X, Yuan J, Xing F, Hu Z, Huang F, et al. Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells. Life Sci 2020; 249: 117448. [DOI:10.1016/j.lfs.2020.117448]
149. Yang L, Xing F, Han X, Li Q, Wu H, Shi H, et al. Astragaloside IV regulates differentiation and induces apoptosis of activated CD4+ T cells in the pathogenesis of experimental autoimmune encephalomyelitis. Toxicol Appl Pharmacol 2019; 362: 105-15. [DOI:10.1016/j.taap.2018.10.024]
150. Yang T, Xu C, Wang ZT, Wang CH. Comparative pharmacokinetic studies of andrographolide and its metabolite of 14-deoxy-12-hydroxy-andrographolide in rat by ultra-performance liquid chromatography-mass spectrometry. Biomed Chromatogr 2013; 27(7): 931-7. [DOI:10.1002/bmc.2884]
151. Yang Z, Kulkarni K, Zhu W, Hu M. Bioavailability and pharmacokinetics of genistein: Mechanistic studies on its ADME. Anticancer Agents Med Chem 2012; 12(10): 1264-80. [DOI:10.2174/187152012803833107]
152. Yang Z, Zhu W, Gao S, Xu H, Wu B, Kulkarni K, et al. Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice. J Pharm Biomed Anal 2010; 53(1): 81-9. [DOI:10.1016/j.jpba.2010.03.011]
153. Yao W, Wang F, Wang H. Immunomodulation of artemisinin and its derivatives. Sci Bull 2016; 61(18): 1399-1406. [DOI:10.1007/s11434-016-1105-z]
154. Yin LL, Lin LL, Zhang L, Li L. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses. Neuropharmacology 2012; 63(5): 851-62. [DOI:10.1016/j.neuropharm.2012.06.025]
155. Yue P, Tao T, Zhao Y, Ren J, Chai X. Huperzine A in rat plasma and CSF following intranasal administration. Int J Pharm 2007; 337(1-2): 127-32. [DOI:10.1016/j.ijpharm.2006.12.029]
156. Zeng MF, Pan LM, Zhu HX, Zhang QC, Guo LW. Comparative pharmacokinetics of baicalin in plasma after oral administration of Huang-Lian-Jie-Du-Tang or pure baicalin in MCAO and sham-operated rats. Fitoterapia 2010; 81(6): 490-6. [DOI:10.1016/j.fitote.2010.01.004]
157. Zeng Y, Gu B, Ji X, Ding X, Song C, Wu F. Sinomenine, an antirheumatic alkaloid, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalolmyelitis. Biol Pharm Bull 2007a; 30(8): 1438-44. [DOI:10.1248/bpb.30.1438]
158. Zeng Y, Song C, Ding X, Ji X, Yi L, Zhu K. Baicalin reduces the severity of experimental autoimmune encephalomyelitis. Braz J Med Biol Res 2007b; 40(7): 1003-10. [DOI:10.1590/S0100-879X2006005000115]
159. Zhang K, Ge Z, Da Y, Wang D, Liu Y, Xue Z, et al. Plumbagin suppresses dendritic cell functions and alleviates experimental autoimmune encephalomyelitis. J Neuroimmunol 2014; 273(1-2): 42-52. [DOI:10.1016/j.jneuroim.2014.05.014]
160. Zhang L, Yang S, Wong LR, Xie H, Ho PCL. In vitro and in vivo comparison of curcumin-encapsulated chitosan-coated poly(lactic-co-glycolic acid) nanoparticles and curcumin/hydroxypropyl-β-cyclodextrin inclusion complexes administered intranasally as therapeutic strategies for Alzheimer's disease. Mol Pharm 2020; 17(11): 4256-69. [DOI:10.1021/acs.molpharmaceut.0c00675]
161. Zhang R, Tian A, Shi X, Yu H, Chen L. Downregulation of IL-17 and IFN-γ in the optic nerve by β-elemene in experimental autoimmune encephalomyelitis. Int Immunopharmacol 2010; 10(7): 738-43. [DOI:10.1016/j.intimp.2010.04.003]
162. Zhang R, Tian A, Zhang H, Zhou Z, Yu H, Chen L. Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance. J Mol Neurosci 2011; 44(1): 31-40. [DOI:10.1007/s12031-010-9483-1]
163. Zhang S, Kan QC, Xu Y, Zhang GX, Zhu L. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis. Mediators Inflamm 2013; 2013: 736085. [DOI:10.1155/2013/736085]
164. Zhang S, Wang J, Pan J. Baicalin-loaded PEGylated lipid nanoparticles: Characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv 2016; 23(9): 3696-703. [DOI:10.1080/10717544.2016.1223218]
165. Zhang WD, Zhang C, Liu RH, Li HL, Zhang JT, Mao C, et al. Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs. Life Sci 2006; 79(8): 808-15. [DOI:10.1016/j.lfs.2006.02.032]
166. Zhang Y, Li X, Ciric B, Ma CG, Gran B, Rostami A, et al. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway. Sci Rep 2015; 5: 17407. [DOI:10.1038/srep17407]
167. Zhang Y, Yin L, Zheng N, Zhang L, Liu J, Liang W, et al. Icariin enhances remyelination process after acute demyelination induced by cuprizone exposure. Brain Res Bull 2017; 130: 180-7. [DOI:10.1016/j.brainresbull.2017.01.025]
168. Zhao G, Peng C, Du W, Wang S. Pharmacokinetic study ofeight coumarins of Radix Angelicae Dahuricae in rats by gas chromatography-mass spectrometry. Fitoterapia 2013; 89: 250-6. [DOI:10.1016/j.fitote.2013.06.007]
169. Zhao X, Kan Q, Zhu L, Zhang GX. Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis. Am J Chin Med 2011; 39(5): 933-41. [DOI:10.1142/S0192415X11009317]
170. Zhou J, Zeng P, Cheng ZH, Liu J, Wang FQ, Qian RJ. Application of hollow fiber liquid phase microextraction coupled with high-performance liquid chromatography for the study of the osthole pharmacokinetics in cerebral ischemia hypoperfusion rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879(23): 2304-10. [DOI:10.1016/j.jchromb.2011.06.022]
171. Zhou R, Zhang F, He PL, Zhou WL, Wu QL, Xu JY, et al. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo. Int Immunopharmacol 2005; 5(13-14): 1895-903. [DOI:10.1016/j.intimp.2005.06.009]
172. Zhou R, Zheng SX, Tang W, He PL, Li XY, Yang YF, et al. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-γ- and bacterial lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 2006; 316(1): 121-8. [DOI:10.1124/jpet.105.093179]
173. Zhou Y, Wang J, Chang Y, Li R, Sun X, Peng L, et al. Caffeic acid phenethyl ester protects against experimental autoimmune encephalomyelitis by regulating T cell activities. Oxid Med Cell Longev 2020; 2020: 7274342. [DOI:10.1155/2020/7274342]
174. Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Patrick KS, Markowitz JS. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: A dose escalation study. Drug Metab Dispos 2013; 41(9): 1679-85. [DOI:10.1124/dmd.113.052423]
175. Zhu L, Pan QX, Zhang XJ, Xu YM, Chu YJ, Liu N, et al. Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling. Exp Mol Pathol 2016; 100(2): 337-43. [DOI:10.1016/j.yexmp.2015.12.006]
176. Zhu Z, Zhao L, Liu X, Chen J, Zhang H, Zhang G, et al. Comparative pharmacokinetics of baicalin and wogonoside by liquid chromatography-mass spectrometry after oral administration of Xiaochaihu Tang and Radix scutellariae extract to rats. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878(24): 2184-90. [DOI:10.1016/j.jchromb.2010.06.021]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.